Exosome-derived COMP partially contributes to EMT in recipient cells by increasing MMP9, MMP3, BMP1, TGFB2, ZEB1, and SNAI2 (ER+ human breast cancer cell line, MCF7 cells) [103] (Figure 5). This evidence concerns the gene ESR1 and breast carcinoma.